Rates of injection in prison in a sample of Australian-injecting drug users

References

• Allwright, S., Bradley, F., Long, J., Barry, J., Thornton, L., & Parry, J. V. (2000). Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: Results of a national cross sectional survey. British Medical Journal, 321(7253), 78–82.
   Google Scholar
• Butler, T., Boonwaat, L., Hailstone, S., Falconer, T., Lems, P., Ginley, T., Read, V., Smith, N, Levy, M., Dore, G., & Kaldor, J. (2007). The 2004 Australian prison entrants blood-borne virus and risk behaviour survey. Australian and New Zealand Journal of Public Health, 31(1), 44–50.
   PubMed Web of Science ®Google Scholar
• Butler, T., Kariminia, A., Levy, M., & Kaldor, J. (2004). Prisoners are at risk for hepatitis C transmission. European Journal of Epidemiology, 19(12), 1119.
   Google Scholar
• Butler, T., Levy, M., Dolan, K., & Kaldor, J. (2003). Drug use and its correlates in an Australian prisoner population. Addiction Research & amp; Theory, 11(2), 89–101.
   Web of Science ®Google Scholar
• Butler, T., & Milner, L. (2003). The 2001 New South Wales inmate health survey. Sydney, NSW: Corrections Health Service.
   Google Scholar
• Butler, T., & Papanastasiou, C. (2008). National Prisoner Entrants’ Blood-borne virus and risk behaviour survey 2004-2007. Perth, Western Australia: National Drug Research Institute, Curtin University of Technology.
   Google Scholar
• Calzavara, L., Burchell, A., Schlossberg, J., Myers, T., Escobar, M., Wallace, E., (2003). Prior opiate injection and incarceration history predict injection use among inmates. Addiction, 98, 1257–1265.
   PubMed Web of Science ®Google Scholar
• Christensen, P., Krarup, H., Niesters, H., Norder, H., & Georgsen, J. (2000). Prevalence and incidence of bloodborne viral infections among Danish prisoners. European Journal of Epidemiology, 16(11), 1043.
   Google Scholar
• Covell, R., Frischer, M., Taylor, A., Goldberg, D., Green, S., McKeganey, N., (1993). Prison experience of injecting drug users in Glasgow. Drug and Alcohol Dependence, 32, 9–14.
   PubMed Web of Science ®Google Scholar
• Dolan, K., Shearer, J., MacDonald, M., Mattick, R., Hall, W., & Wodak, A. (2003). A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug and Alcohol Dependence, 72, 59–65.
   PubMed Web of Science ®Google Scholar
• Dolan, K., Teutsch, S., Scheuer, N., Levy, M., Rawlinson, W., Kaldor, J., (2010). Incidence and risk for acute hepatitis C infection during imprisonment in Australia. European Journal of Epidemiology, 25(2), 143.
   PubMed Web of Science ®Google Scholar
• Dolan, K., Wodak, A., & Hall, W. (1998). Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug and Alcohol Review, 17(2), 153.
   PubMed Web of Science ®Google Scholar
• Dyer, J., & Tolliday, L. (2009). Hepatitis C education and support in Australian prisons: Preliminary findings of a nationwide survey. Health Promotion Journal of Australia, 20(1), 37–41.
   Google Scholar
• Fazel, S., Bains, P., & Doll, H. (2006). Substance abuse and dependence in prisoners: A systematic review. Addiction, 101, 181–191.
   PubMed Web of Science ®Google Scholar
• Gough, E., Kempf, M., Graham, L., Manzanero, M., Hook, E., Batolucci, A., (2010). HIV and hepatitis B and C incidence rates in US Correctional populations and high risk groups: A systematic review and meta-analysis. BMC Public Health, 10, 777–791.
   PubMed Web of Science ®Google Scholar
• Hando, J., O’Brien, S., Darke, S., Maher, L., & Hall, W. (1997). The Illicit Drug Reporting System trial: Final report. Sydney: National Drug Institute, University of New South Wales.
   Google Scholar
• Heimer, R., Catania, H., Newman, R., Zambrando, J., Brunet, A., & Ortiz, A. (2006). Methadone maintenance in prison: Evaluation of a pilot program in Puerto Rico. Drug and Alcohol Dependence, 83, 122–129.
   PubMed Web of Science ®Google Scholar
• IBM. (2009). SPSS Statistics v19.0.
   Google Scholar
• Indig, D., Topp, L., Ross, B., Mamoon, H., Border, B., Kumar, S., (2010). 2009 NSW Inmate health survey: Key findings report. Sydney, NSW: Justice Health.
   Google Scholar
• Iversen, J., Topp, L., & Maher, L. (2011). Australian NSP Survey: Prevalence of HIV, HCV and injecting and sexual behaviour among Needles and Syringe Program attendees. National data report 1995–2010. Sydney, NSW: The Kirby Institute for infection and immunity in society, UNSW.
   Google Scholar
• Jurgens, R., Nowak, M., & Day, M. (2011). HIV and incarceration: Prisons and detention. Journal of the International AIDS Society, 14, 26–43.
   PubMed Web of Science ®Google Scholar
• Kinner, S, Jenkinson, R, Gouillou, M., & Milloy, M. (2012), High-risk drug-use practices among a large sample of Australian prisoners. Drug and Alcohol Dependence, Volume 126, 156–160.
   Google Scholar
• Levy, M., & Treloar, C. (2012). Harm minimisation in Australian prisons–health protection still depends on where you serve your time. Medical Journal of Australia, 197(7), 382.
   Google Scholar
• Macalino, G., Vlahov, D., Sanford-Colby, S., Patel, S., Sabin, K., Salas, C., (2004). Prevalence and incidence of HIV, hepatitis B virus, and hepatitis Cvirus infections among males in Rhode Island prisons. American Journal of Public Health, 94(7), 1218–1223.
   PubMed Web of Science ®Google Scholar
• Malliori, M., Sypsa, V., Psichogiou, M., Touloumi, G., Skoutelis, A., Tassopoulos, N., (1998). A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction, 93(2), 243–251.
   PubMed Web of Science ®Google Scholar
• Pollini, R., Alvelais, J., Gallardo, M., Vera, A., Lazada, R., Magis-Rodriquez, C., (2009). The harm inside: Injection during incarceration among male injection drug users in Tijuana, Mexico. Drug and Alcohol Dependence, 103, 52–58.
   PubMed Web of Science ®Google Scholar
• Rotily, M., Weilandt, C., Bird, S., Kall, K., Van Haastrecht, H., Iandolo, E., (2001). Surveillance of HIV infection and related risk behaviour in European prisons. European Journal of Public Health, 11(3), 243–250.
   PubMed Web of Science ®Google Scholar
• Stafford, J., & Burns, L. (2011). Australian Drug trends 2010. Findings from the Illicit Drug Reporting System (IDRS). Sydney.
   Google Scholar
• Stoove, M., & Kirwan, A. (2010). External component of drug policies and services and their subsequent effects on prisoners and staff within the Alexander Maconchie Centre. Melbourne, VIC: Burnet Institute.
   Google Scholar
• Stover, H., & Michels, I. (2010). Drug use and opioid substitution treatment for prisoners. Harm Reduction Journal, 7, 17.
   Google Scholar
• Stöver, H., & Nelles, J. (2003). Ten years of experience with needle and syringe exchange programmes in European prisons. International Journal of Drug Policy, 14(5–6), 437–444.
   Google Scholar
• Teutsch, S., Luciani, F., Scheuer, N., McCredie, L., Hosseiny, P., Rawlinson, W., (2010). Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health, 10, 633.
   PubMed Web of Science ®Google Scholar
• Vlahov, D., Nelson, K. E., Quinn, T. C., & Kendig, N. (1995). Prevalence and Incidence of hepatitis C virus infection among male prisoner inmates in Maryland. European Journal of Epidemiology, 9(5), 566–569.
   Google Scholar
• Weinbaum, C., Sabin, K., & Santibanez, S. (2005). Hepatitis B, hepatitis C, and HIV in correctional populations: A review of epidemiology and prevention. Acquired Immune Deficiency Syndrome, 19(3), S41–S46.
   Google Scholar